Default Category
-
Bajaj RE60: The Branding Challenge of Disruptive Innovation
Srividya Raghavan; Sourabh BhattacharyaCase IVEY-9B16A014-EMarketingBajaj Auto Limited (BAL), the world’s largest manufacturer of three-wheel vehicles, was about to launch India’s first quadricycle, built indigenously for applications that were uniquely useful for urban transportation in developing markets such as India. The four-wheel vehicle was being launched as a completely new category in the Indian market by BAL’s Commercial Vehicle division. The dilemma facing the BAL team was whether to brand the new prod...Starting at €8.20
-
Pluggin In the Consumer: The Adoption of Electrically Powered Vehicles in the U.S.
Ofek, Elie; Ribatt, Polly RossCase HBS-510076-EMarketingHow will U.S. consumers respond to the proliferation of alternative-fuel vehicles, such as cars powered partially or completely by electricity, in the coming decade? After a century in which fossil-fuel-powered vehicles dominated the market, it appeared consumers would have an unprecedented level of choice as to the type of car they purchased and drove. Automakers were introducing various models that used electricity for power, and other power so...Starting at €8.20
-
HCL Technologies: Pushing the Billion-Dollar Website
Srividya Raghavan; Apurva Chamaria; Gaurav KakkarCase IVEY-9B16A053-EMarketing, StrategyIn 2014, India’s HCL Technologies emerged as one of just eight 21st-century listed technology companies in the world to surpass US$1 billion in net profits, $5 billion in revenue, and $15 billion in market capitalization. When most companies were using their websites as online information pages, HCL Technologies converted its legacy website into an effective lead-generation vehicle. Within one year of implementation, the website began generating ...Starting at €8.20
-
Tengion: Bringing Regenerative Medicine to Life
Ofek, Elie; Ribatt, Polly RossCase HBS-510031-EMarketingTengion is a young biotech company that is at the frontier of regenerative medicine; a nascent field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late 2008 Tengion management faces a difficult dilemma. In light of the financial crises, the company needs to manage cash burn by prioritizing its R&D efforts. CEO Nichtberger needs t...Starting at €8.20